查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1575077

小動物影像（體內）市場規模、佔有率、趨勢分析報告：按模式、按應用、按地區、細分市場預測，2024-2030 年

Small Animal Imaging (In-vivo) Market Size, Share & Trends Analysis Report By Modality (Optical Imaging Systems, Micro-magnetic Resonance Imaging, Nuclear Imaging), By Application, By Region, And Segment Forecasts, 2024 - 2030
出版日期: | 出版商: Grand View Research | 英文 110 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

小動物影像（體內）市場成長與趨勢：

根據Grand View Research, Inc.最新報告顯示，2024年至2030年，全球小動物影像（體內）市場規模將以7.7%的複合年成長率擴張，預計到2030年將達到18.7億美元。

預計越來越多的病理狀況需要密切調查以開發治療方法，這將推動預測期內小動物影像的需求。

這些設備在作用機制闡明、藥物受體靶向和表觀遺傳學研究等應用中的重要性預計將推動市場的顯著成長。小動物影像（體內）市場的主要驅動力是技術創新，例如使用其他模式的高解析度 MRI、研究和製藥機構數量的增加、CRO 對臨床前研究的投資增加以及多功能性。臨床前成像。

小動物影像（體內）市場報告亮點

  • 與其他設備相比，光學成像由於操作快速簡便且相對具有成本效益，將在 2023 年成為最大的細分市場。
  • 由於 MicroMRI 技術在發育中的小鼠胚胎和新生兒的解剖和功能分析中的多種應用，預計 MicroMRI 技術將成為預測期內成長最快的領域。
  • 2023年，生物分佈和治療反應監測在收益方面佔據市場主導地位。
  • 由於癌症盛行率的增加以及政府對癌症診斷研究的舉措不斷增加，癌細胞檢測領域預計將顯著成長。
  • 就 2023 年銷售額而言，北美是最大的地區。大量的臨床前研究、對快速和先進方法不斷成長的需求、成熟的醫療基礎設施、與技術進步相關的有利研發平台是推動該區域市場的關鍵因素。
  • 由於擁有大量的臨床研究機構、製藥公司和診斷設備製造商，歐洲將在2023年成為第二大地區。
  • 由於臨床研究活動的增加、目標人口的成長和新興經濟體的成長，亞太地區預計將成為預測期內成長最快的地區。
  • 主要企業包括 Promega Corporation, Inc.、Miltenyi Biotec GmbH、PerkinElmer, Inc.、FujiFilm Holding Corporation、Siemens AG、Thermo Fisher Scientific、Bruker Corporation、PerkinElmer Inc. 和 Aspect Imaging Ltd。

目錄

第1章調查方法與範圍

第 2 章執行摘要

第3章小動物影像（體內）市場變數、趨勢與範圍

  • 市場介紹/系統展望
  • 市場規模及成長前景
  • 市場動態
    • 市場促進因素分析
    • 市場限制因素分析
  • 小動物影像（體內）市場分析工具
    • 波特的分析
    • PESTEL分析

第4章 小動物影像（體內）市場：模態估計與趨勢分析

  • 細分儀表板
  • 小動物影像（體內）市場：模態波動分析，2023/2030
  • 光學成像系統
  • 顯微磁振造影
  • 核子造影
  • 其他成像方式

第5章小動物影像（體內）市場：應用評估與趨勢分析

  • 細分儀表板
  • 小動物影像（體內）市場：2023 年和 2030 年應用變化分析
  • 監測藥物治療反應
  • 生物分佈研究
  • 癌細胞檢測
  • 生物標記
    • 2018-2030 年生物標記收益估計與預測
  • 縱貫研究
  • 表觀遺傳學

第6章小動物影像（體內）市場：區域估計與趨勢分析

  • 2023 年和 2030 年按地區分類的小動物成像（體內）市場佔有率，百萬美元
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 丹麥
    • 瑞典
    • 挪威
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 韓國
    • 泰國
  • 拉丁美洲
    • 巴西
    • 阿根廷
  • 中東/非洲
    • 南非
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 科威特

第7章 競爭格局

  • 最新趨勢與影響分析：主要市場參與企業
  • 公司分類
  • 企業熱力圖分析
  • 公司簡介
    • Aspect Imaging Ltd
    • PerkinElmer, Inc.
    • FUJIFILM Holdings Corporation
    • Miltenyi Biotec
    • Thermo Fisher Scientific Inc
    • Bruker
    • Siemens AG
    • Promega Corporation
    • Mediso
簡介目錄
Product Code: 978-1-68038-645-5

Small Animal Imaging (In-vivo) Market Growth & Trends:

The global small animal imaging (in-vivo) market size is expected to reach USD 1.87 billion by 2030, expanding at a CAGR of 7.7% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising number of medical conditions requiring precise research for development of treatment options is anticipated to stoke the demand for small animal imaging over the forecast period.

Importance of these devices in applications such as defining mechanism of action, drug receptor targeting, and epigenetic research studies are projected to provide substantial growth for the market. Some of the major drivers of small animal imaging (in-vivo) market are technical innovations such as high-resolution MRI with other modalities, growing number of research and pharmaceutical organizations, increasing investments of CROs in pre-clinical studies, and rising adoption of multi-functional pre-clinical imaging.

Small Animal Imaging (In-vivo) Market Report Highlights:

  • Optical imaging was the largest segment in 2023 owing to rapid and easy operations and relatively cost-effective in comparison to other devices
  • Micro-MRI technology is anticipated to be the fastest growing segment over the forecast period due varied applications during anatomical and functional analysis in developing mouse embryos and neonates
  • In 2023, bio-distribution and monitoring the treatment response dominated the market in terms of revenue
  • The cancer cell detection segment is expected to show substantial growth due to the increasing prevalence of cancer and rising government initiatives for cancer diagnostics research
  • North America was the largest region in terms of revenue in 2023. Vast pre-clinical research, increasing demand for rapid and advanced methods, established healthcare infrastructure, and favorable platform for R&D pertaining to technological advancements are the key factors driving the regional market
  • Europe was the second largest region in 2023, due to a large number of clinical research and pharmaceutical organizations and diagnostic device manufacturers
  • Asia Pacific is projected to be the fastest growing region over the forecast period owing to increasing clinical research activities, rising base of target population, and emerging economies
  • Some of the key players are Promega Corporation, Inc.; Miltenyi Biotec GmbH; PerkinElmer, Inc.; FujiFilm Holding Corporation; Siemens AG; Thermo Fisher Scientific; Bruker Corporation; PerkinElmer Inc.; and Aspect Imaging Ltd

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation and Scope
  • 1.2. Market Definitions
  • 1.3. Research Methodology
    • 1.3.1. Information Procurement
    • 1.3.2. Information or Data Analysis
    • 1.3.3. Market Formulation & Data Visualization
    • 1.3.4. Data Validation & Publishing
  • 1.4. Research Scope and Assumptions
    • 1.4.1. List of Data Sources

Chapter 2. Executive Summary

  • 2.1. Market Outlook
  • 2.2. Segment Outlook
  • 2.3. Competitive Insights

Chapter 3. Small Animal Imaging (In-vivo) Market Variables, Trends, & Scope

  • 3.1. Market Introduction/Lineage Outlook
  • 3.2. Market Size and Growth Prospects (USD Million)
  • 3.3. Market Dynamics
    • 3.3.1. Market Drivers Analysis
    • 3.3.2. Market Restraints Analysis
  • 3.4. Small Animal Imaging (In-vivo) Market Analysis Tools
    • 3.4.1. Porter's Analysis
      • 3.4.1.1. Bargaining power of the suppliers
      • 3.4.1.2. Bargaining power of the buyers
      • 3.4.1.3. Threats of substitution
      • 3.4.1.4. Threats from new entrants
      • 3.4.1.5. Competitive rivalry
    • 3.4.2. PESTEL Analysis
      • 3.4.2.1. Political landscape
      • 3.4.2.2. Economic and Social landscape
      • 3.4.2.3. Technological landscape
      • 3.4.2.4. Environmental landscape
      • 3.4.2.5. Legal landscape

Chapter 4. Small Animal Imaging (In-vivo) Market: Modality Estimates & Trend Analysis

  • 4.1. Segment Dashboard
  • 4.2. Small Animal Imaging (In-vivo) Market: Modality Movement Analysis, 2023 & 2030 (USD Million)
  • 4.3. Optical Imaging Systems
    • 4.3.1. Optical Imaging Systems Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.2. Bioluminescence Imaging
      • 4.3.2.1. Bioluminescence Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.3. Cerenkov Luminescence Imaging
      • 4.3.3.1. Cerenkov Luminescence Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.3.4. Fluorescence Imaging
      • 4.3.4.1. Fluorescence Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.4. Micro-magnetic Resonance Imaging
    • 4.4.1. Micro-magnetic Resonance Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.5. Nuclear Imaging
    • 4.5.1. Nuclear Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.2. Micro Positron Emission Tomography (Micro PET)
      • 4.5.2.1. Micro Positron Emission Tomography (Micro PET) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.5.3. Micro Single Photon Emission Computerized Tomography (Micro SPECT)
      • 4.5.3.1. Micro Single Photon Emission Computerized Tomography (Micro SPECT) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 4.6. Other Imaging Modalities
    • 4.6.1. Other Imaging Modalities Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.2. Micro Computerized Tomography Imaging
      • 4.6.2.1. Micro Computerized Tomography Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 4.6.3. Micro Ultrasound Imaging
      • 4.6.3.1. Micro Ultrasound Imaging Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Small Animal Imaging (In-vivo) Market: Application Estimates & Trend Analysis

  • 5.1. Segment Dashboard
  • 5.2. Small Animal Imaging (In-vivo) Market: Application Movement Analysis, 2023 & 2030 (USD Million)
  • 5.3. Monitoring Drug Treatment Response
    • 5.3.1. Monitoring Drug Treatment Response Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.4. Biodistribution Studies
    • 5.4.1. Biodistribution Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.5. Cancer Cell Detection
    • 5.5.1. Cancer Cell Detection Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.6. Biomarkers
    • 5.6.1. Biomarkers Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.7. Longitudinal Studies
    • 5.7.1. Longitudinal Studies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 5.8. Epigenetics
    • 5.8.1. Epigenetics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Small Animal Imaging (In-vivo) Market: Regional Estimates & Trend Analysis

  • 6.1. Small Animal Imaging (In-vivo) Market Share, By Region, 2023 & 2030, USD Million
  • 6.2. North America
    • 6.2.1. North America Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.2. U.S.
      • 6.2.2.1. U.S. Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.3. Canada
      • 6.2.3.1. Canada Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.2.4. Mexico
      • 6.2.4.1. Mexico Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.3. Europe
    • 6.3.1. Europe Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.2. UK
      • 6.3.2.1. UK Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.3. Germany
      • 6.3.3.1. Germany Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.4. France
      • 6.3.4.1. France Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.5. Italy
      • 6.3.5.1. Italy Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.6. Spain
      • 6.3.6.1. Spain Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.7. Denmark
      • 6.3.7.1. Denmark Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.8. Sweden
      • 6.3.8.1. Sweden Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.3.9. Norway
      • 6.3.9.1. Norway Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.4. Asia Pacific
    • 6.4.1. Asia Pacific Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.2. Japan
      • 6.4.2.1. Japan Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.3. China
      • 6.4.3.1. China Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.4. India
      • 6.4.4.1. India Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.5. Australia
      • 6.4.5.1. Australia Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.6. South Korea
      • 6.4.6.1. South Korea Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.4.7. Thailand
      • 6.4.7.1. Thailand Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.5. Latin America
    • 6.5.1. Latin America Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.2. Brazil
      • 6.5.2.1. Brazil Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.5.3. Argentina
      • 6.5.3.1. Argentina Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
  • 6.6. Middle East and Africa
    • 6.6.1. Middle East and Africa Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.2. South Africa
      • 6.6.2.1. South Africa Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.3. Saudi Arabia
      • 6.6.3.1. Saudi Arabia Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.4. UAE
      • 6.6.4.1. UAE Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)
    • 6.6.5. Kuwait
      • 6.6.5.1. Kuwait Small Animal Imaging (In-vivo) Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Competitive Landscape

  • 7.1. Recent Developments & Impact Analysis by Key Market Participants
  • 7.2. Company Categorization
  • 7.3. Company Heat Map Analysis
  • 7.4. Company Profiles
    • 7.4.1. Aspect Imaging Ltd
      • 7.4.1.1. Participant's Overview
      • 7.4.1.2. Financial Performance
      • 7.4.1.3. Product Benchmarking
      • 7.4.1.4. Recent Developments/ Strategic Initiatives
    • 7.4.2. PerkinElmer, Inc.
      • 7.4.2.1. Participant's Overview
      • 7.4.2.2. Financial Performance
      • 7.4.2.3. Product Benchmarking
      • 7.4.2.4. Recent Developments/ Strategic Initiatives
    • 7.4.3. FUJIFILM Holdings Corporation
      • 7.4.3.1. Participant's Overview
      • 7.4.3.2. Financial Performance
      • 7.4.3.3. Product Benchmarking
      • 7.4.3.4. Recent Developments/ Strategic Initiatives
    • 7.4.4. Miltenyi Biotec
      • 7.4.4.1. Participant's Overview
      • 7.4.4.2. Financial Performance
      • 7.4.4.3. Product Benchmarking
      • 7.4.4.4. Recent Developments/ Strategic Initiatives
    • 7.4.5. Thermo Fisher Scientific Inc
      • 7.4.5.1. Participant's Overview
      • 7.4.5.2. Financial Performance
      • 7.4.5.3. Product Benchmarking
      • 7.4.5.4. Recent Developments/ Strategic Initiatives
    • 7.4.6. Bruker
      • 7.4.6.1. Participant's Overview
      • 7.4.6.2. Financial Performance
      • 7.4.6.3. Product Benchmarking
      • 7.4.6.4. Recent Developments/ Strategic Initiatives
    • 7.4.7. Siemens AG
      • 7.4.7.1. Participant's Overview
      • 7.4.7.2. Financial Performance
      • 7.4.7.3. Product Benchmarking
      • 7.4.7.4. Recent Developments/ Strategic Initiatives
    • 7.4.8. Promega Corporation
      • 7.4.8.1. Participant's Overview
      • 7.4.8.2. Financial Performance
      • 7.4.8.3. Product Benchmarking
      • 7.4.8.4. Recent Developments/ Strategic Initiatives
    • 7.4.9. Mediso
      • 7.4.9.1. Participant's Overview
      • 7.4.9.2. Financial Performance
      • 7.4.9.3. Product Benchmarking
      • 7.4.9.4. Recent Developments/ Strategic Initiatives